Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/26/1991 | US4996159 Purified polypeptides |
02/26/1991 | US4996155 Insect control |
02/26/1991 | US4996148 Aerobic fermentation of Kibdelosporangium |
02/26/1991 | US4996074 Tailored beta-prime stable triglyceride hardstock |
02/26/1991 | US4996060 Device comprising liner for protecting fluid sensitive medicament |
02/26/1991 | US4996057 Human placental tissue proteins and a condensation product of n-methyl-p-methoxyphenethylamine with formaldehyde; hair growth |
02/26/1991 | US4996050 Single chain pro-urokinase and plasminogin |
02/26/1991 | CA2023969A1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
02/25/1991 | CA2023819A1 Gibbon ape leukemia virus receptor |
02/24/1991 | WO1991002977A1 Wound healing preparations containing heparanase |
02/24/1991 | WO1991002743A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
02/24/1991 | CA2065744A1 Wound healing preparations containing heparanase |
02/24/1991 | CA2065010A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
02/24/1991 | CA2023779A1 Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders |
02/23/1991 | CA2022443A1 Pulmonary surfactant protein fragments |
02/22/1991 | WO1991002744A1 Bone-specific protein |
02/22/1991 | WO1991002719A2 Cck antagonists |
02/22/1991 | CA2064897A1 Cck antagonists |
02/22/1991 | CA2064878A1 Bone-specific protein |
02/21/1991 | WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
02/21/1991 | WO1991002079A1 Monoclonal antibodies against a tumor-associated antigen |
02/21/1991 | WO1991002078A1 Tumour necrosis factor binding ligands |
02/21/1991 | WO1991002067A1 Regulation of nerve growth factor synthesis in the central nervous system |
02/21/1991 | WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
02/21/1991 | WO1991002062A2 C-erbb-2 external domain: gp75 |
02/21/1991 | WO1991002061A1 Recombinant human thyroid peroxidase |
02/21/1991 | WO1991002058A1 Production of vascular endothelial cell growth factor |
02/21/1991 | WO1991002056A1 Cell lineages expressing a biologically active ix factor |
02/21/1991 | WO1991002004A1 IMMUNOGENIC GLYCOPROTEINS OF HUMAN CYTOMEGALOVIRUS gCII |
02/21/1991 | WO1991002001A1 A megakaryocytopoietic factor |
02/21/1991 | WO1991001999A1 Phospholipase a2 inhibiting protein originating in inflamed region, production thereof, and gene therefor |
02/21/1991 | WO1991001976A1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same |
02/21/1991 | WO1991001754A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
02/21/1991 | WO1991001752A1 Immunosuppressive monoclonal antibodies, hybridomas and methods of transplantation |
02/21/1991 | WO1991001748A1 Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders |
02/21/1991 | WO1991001747A1 Method of treating infertility or sub-fertility in adult men, and the use of preparations in the method. |
02/21/1991 | WO1991001746A1 Thy-1 receptor and its use for regenerating nerve cell processes |
02/21/1991 | WO1991001744A2 Uses of interleukin-4 and method for purifying it |
02/21/1991 | WO1991001743A1 Stabilized protein or peptide conjugates |
02/21/1991 | WO1991001723A1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
02/21/1991 | WO1991001720A1 Composition and method of promoting hard tissue healing |
02/21/1991 | WO1991001639A1 Methods and compositions for ameliorating the symptoms of sepsis |
02/21/1991 | WO1991000725A3 Amino acid analog cck antagonists |
02/21/1991 | WO1990015618A3 Srif-related peptides and uses thereof |
02/21/1991 | WO1990011782A3 Immunoconjugates and prodrugs and their use in association for drug delivery |
02/21/1991 | DE3926287A1 Use of omega-conotoxin GVIA or its analogues - as pre-synaptic calcium ion antagonists in sympatholytic treatment of circulation disorders of extremities, e.g. hypoxia |
02/21/1991 | CA2064753A1 Uses of interleukin-4 and method for purifying it |
02/21/1991 | CA2064738A1 Megakaryocytopoietic factor |
02/21/1991 | CA2064023A1 Method of treating infertility or sub-fertility in adult men, and the use of preparations in the method |
02/21/1991 | CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
02/21/1991 | CA2039153A1 Cell lineage expressing a factor ix biologically active |
02/20/1991 | EP0413622A1 Albumin derivatives with therapeutic functions |
02/20/1991 | EP0413383A1 Mutants of human interleukin-3 |
02/20/1991 | EP0413277A1 Peptide antagonists of bradykinin |
02/20/1991 | EP0413209A1 LHRH analogs |
02/20/1991 | EP0413188A2 Method for producung an unmodified intravenous IgM- and/or IgA-containing immunoglobulin preparation |
02/20/1991 | EP0413187A1 Method for producing an unmodified intravenous IgM- and/or IgA containing immunoglobulin preparation |
02/20/1991 | EP0413024A1 Protein having activity of inhibiting inflammation-inducing phospholipase a2 |
02/20/1991 | CN1049353A Cyclic neurokinin a antagonists |
02/19/1991 | WO1991002755A1 Fibulin |
02/19/1991 | WO1991002750A1 Novel inhibitors of thrombin |
02/19/1991 | WO1991002704A1 Ferritin analogs |
02/19/1991 | WO1991002545A1 Pharmaceutical compositions |
02/19/1991 | WO1991002538A1 Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing |
02/19/1991 | US4994559 Human basic fibroblast growth factor |
02/19/1991 | US4994556 Antitumor agents |
02/19/1991 | US4994554 Probursin |
02/19/1991 | US4994486 Dopaminergic compounds |
02/19/1991 | US4994477 Hypotensive agents |
02/19/1991 | US4994441 Kappa-caseino-glycopeptides or desialylated derivatives |
02/19/1991 | US4994440 Administering phospholipidyl tripeptides |
02/19/1991 | US4994270 Animal growth regulators |
02/19/1991 | US4994269 Inhalation or injection via trachea |
02/19/1991 | CA2065044A1 Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing |
02/19/1991 | CA2064818A1 Fibulin |
02/19/1991 | CA2064069A1 Ferritin analogs |
02/19/1991 | CA2023521A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
02/19/1991 | CA1280379C Peptides and compositions |
02/19/1991 | CA1280369C Pharmaceutical with anti-tumor effect |
02/18/1991 | WO1991002795A1 Mutant pseudorabies virus, and vaccines containing the same |
02/18/1991 | CA2065002A1 Mutant pseudorabies virus, and vaccines containing the same |
02/17/1991 | CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof |
02/16/1991 | WO1991002747A1 Tuftsin analogs |
02/16/1991 | CA2064731A1 Tuftsin analogs |
02/16/1991 | CA2023250A1 Cleavage site blocking antibody to prohormone proteins and uses thereof |
02/13/1991 | EP0412951A1 Peptides blocking cell attachment to S-laminin |
02/13/1991 | EP0412841A1 Human thrombomodulin derivatives |
02/13/1991 | EP0412766A1 Peptide fragments of HIV |
02/13/1991 | EP0412762A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
02/13/1991 | EP0412699A2 Nitrosothiol derivatives, their production and use |
02/13/1991 | EP0412595A1 Antiherpetic agents |
02/13/1991 | EP0412557A1 Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor |
02/13/1991 | EP0412554A2 Sustained-release preparation for administration into brain |
02/13/1991 | EP0412542A2 Cyclic neurokinin antagonists |
02/13/1991 | EP0412526A2 Expression vector for hirudin, hirudin fusion protein, transformed microorganism, and method for production of hirudin |
02/13/1991 | EP0412508A1 Analogues of vasopressin, their preparation and pharmaceutical use |
02/13/1991 | EP0412486A1 Antibodies to TNF binding protein I and F (ab) fragments thereof |
02/13/1991 | EP0412466A2 Preparation of a stable factor VIII |
02/13/1991 | EP0412350A2 Renininhibitors, procedure for their preparation and use as medicaments |
02/13/1991 | EP0412211A1 Cancer therapy system |